Start here if you're new
what it is
Health In Tech sells tools that help small businesses quote and manage health plans.
how it gets paid
Last year Health In Tech made $19M in revenue.
what just happened
Health In Tech printed $26M of quarterly revenue and $0.03 EPS, while consensus still shows no estimate.
At a glance
n/a balance sheet
122.0x trailing p/e — you're paying up for this one
5.1% return on capital — nothing to write home about
$0.01 fy2024 eps est
$20M fy2024 rev est
What they do
Health In Tech sells tools that help small businesses quote and manage health plans.
eDIYBS, the web-based quoting tool, sits inside your broker workflow, so leaving means redoing the paperwork. The company also reports 65.1% gross margin and 73 employees, which is a lot of margin for a $20M business.
How they make money
$19M
annual revenue
total revenue
$19M
n/a
The products that matter
insurance marketplace technology
Platform & Marketplace
$12M · about 63% of revenue shown
this is the growth engine. it produced $12M of the $20M revenue base and was growing 90% in the latest quarter disclosed here. if you like the story, this is the piece you actually like.
growth driver
insurance administration services
Insurance Services
$7M · about 37% of revenue shown
this part of the business matters at $7M, but the page gives no growth rate. that's a real information gap when you're trying to judge whether revenue quality matches the headline.
thin disclosure
profitability profile
Early-stage earnings
$0.01 eps est · 4.5% operating margin
earnings exist, but barely. operating margin is what the business keeps after running itself. 4.5% means less than five cents of operating profit for each $1 of revenue.
not mature yet
Key numbers
122.0x
trailing p/e
P/E means price to earnings, or what you pay for $1 of profit. At 122.0x, you are paying luxury money for tiny earnings.
65.1%
gross margin
Gross margin means money left after direct costs. At 65.1%, the company keeps $65.10 of every $100 before overhead.
7.9%
operating margin
Operating margin means profit after overhead. At 7.9%, the company keeps $7.90 of every $100 after running the shop.
$0M
long-term debt
Long-term debt means borrowed money due later. At $0M, there is no interest bill eating the little profit the company makes.
Financial health
n/a
strength
- balance sheet grade n/a
- long-term debt $0M (0% of capital)
n/a — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for HIT right now.
source: institutional data · return history unavailable
What just happened
beat estimates
Health In Tech printed $26M of quarterly revenue and $0.03 EPS, while consensus still shows no estimate.
Revenue was up 204% vs. prior year, and gross margin reached 65.1%. The weird part is the data stack: EDGAR shows $26M this quarter, while consensus TTM revenue sits at $20M.
$26M
revenue
$0.03
eps
65.1%
gross margin
the number that mattered
The $26M quarterly revenue matters because it is larger than the $20M TTM revenue in consensus data. That gap makes the story hard to read.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the main risk is simple: platform revenue growth dropping hard from 90.4%. when a $102M stock trades at 122.0x earnings on a $20M revenue base, slowing growth is not a side issue. it's the whole setup.
high
growth deceleration
The current setup assumes the 90.4% quarterly revenue growth rate is more than a one-quarter burst. If that pace drops hard, the 122.0x p/e stops looking optimistic and starts looking detached.
valuation risk
high
earnings are too thin to absorb mistakes
The company earned just $0.01 per share last quarter and the next quarter forecast sits at -$0.01. That's a very small cushion. A modest operating miss can flip the profit story back into a loss story.
execution risk
med
limited disclosure on segment quality
We have $12M for Platform & Marketplace and $7M for Insurance Services, but only one visible growth rate. When disclosure is this thin, you are underwriting more uncertainty than the headline numbers suggest.
analysis risk
med
tiny sponsorship, fragile sentiment
The largest disclosed positions here are Ancora Advisors at $389K and Two Sigma at $386K. Those are real holders, but not heavyweight sponsorship. In a small cap, thin sponsorship usually means price swings arrive fast.
liquidity risk
What would change our mind on the cautious view: another quarter that keeps revenue growth near 90.4% while profitability holds around breakeven or better. What would make us more negative: another estimate cut after the move from $0.01 to -$0.01.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
platform growth staying above the hype line
The only disclosed high-growth number is 90.4%. If that starts falling quickly, you will probably feel it in the multiple before you see it in annual revenue.
calendar
q4 2025 earnings report
Mar 25, 2026 is the next visible checkpoint. The immediate question is whether the company lands around the revised -$0.01 EPS forecast without damaging the growth narrative.
risk
operating margin above 4.5%
A 4.5% operating margin leaves very little slack. If revenue keeps growing but margin goes backward, you are watching a growth story that is not turning into business quality.
trend
whether institutions get bigger
Ancora Advisors at $389K and Two Sigma at $386K are small footholds, not conviction-sized stakes. If sponsorship stays this light, volatility will likely stay high too.
Analyst rankings
coverage depth
thin
There isn't enough broad analyst coverage here to lean on published rankings with confidence. in human-speak, you are doing more of the work yourself on this one.
near-term estimate trend
down
The next quarter EPS view moved from $0.01 to -$0.01. That's a small number change and a meaningful sentiment downgrade.
source: institutional data
Institutional activity
institutional ownership data for HIT is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$1
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive